Relationship of Common Variants in Krüppel-like Factor 7 Gene With Susceptibility and Prognosis of Oral Squamous Cell Carcinoma

doi:10.21203/rs.3.rs-48539/v1

Download PDF

Primary research

Relationship of Common Variants in Krüppel-like Factor 7 Gene With Susceptibility and Prognosis of Oral Squamous Cell Carcinoma

https://doi.org/10.21203/rs.3.rs-48539/v1

This work is licensed under a CC BY 4.0 License

Version 1

posted

You are reading this latest preprint version

Background: The aim of this study was to assess the prognostic value of Krüppel-like factor 7 (KLF7) for patients with oral squamous cell carcinoma(OSCC).

Methods: The expression of KLF7 was detected by quantitative real-time polymerase chain reaction (qRT-PCR) in pairs of tumor tissues and adjacent non-tumor tissues of OSCC. Chi-square (χ²) test was applied to evaluate the association of KLF7 expression with clinicopathological characteristics of OSCC patients. Overall survival was estimated using the Kaplan-Meier method with log rank test. The cox proportional hazards model was used for univariate and multivariate analyses.

Results: The expression of KLF7 was remarkably increased in OSCC tissues compared with adjacent non-tumor tissues (P<0.001). KLF7 expression was related to TNM stage (P=0.006), tumor size (P=0.010), smoking (P=0.006) and drinking (P=0.000). Kaplan-Meier analysis showed that OSCC patients with high KLF7 expression had a poorer overall survival than those with low expression (log rank test, P=0.018). Moreover, multivariate analyses showed that KLF7 was an independent prognostic factor for OSCC (P=0.002 HR=2.645 95%CI: 1.426-4.906).

Conclusion: Decreased expression of KLF7 may be a potential unfavorable prognostic factor for patients with OSCC.

Cancer Biology

Krüppel-like factor 7

Oral squamous cell carcinoma

Prognosis

Oral squamous cell carcinoma (OSCC) is one of the most common forms of oral cancer worldwide, and its morbidity has been rapidly increasing in Asian countries in the past decade [1]. There are several risk factors confirmed for patients with OSCC, such as tobacco smoking, alcohol consumption, human papillomavirus infection, etc [2–4]. The conventional treatments for OSCC include surgical treatment, chemotherapy, radiotherapy. In the past few years, the therapeutic strategies for OSCC have been significantly improved, but the five-year survival of the patients still remains unsatisfactory, especially those diagnosed with advanced stages [5–7]. The aggressive tumor progression and high recurrence rate may be responsible for the poor clinical outcomes [8]. Until now, OSCC progression evaluation is mainly dependent on TNM staging. However, the TNM system is based on clinical parameters of the cases. The histopathological features as well as the interaction between the tumor and host are not considered, which may cause bias to the final results [9]. Therefore, novel biomarkers are in urgent need to evaluate tumor progression and guide treatments in patients with OSCC.

Krüppel-like factors (KLFs) are a group of DNA-binding transcriptional regulators which contain zinc fingers. The family plays important roles in a variety of biological processes, such as cell stemness, proliferation, differentiation, apoptosis, and energy metabolism [10–12]. Krüppel-like factor 7 (KLF7) is a member of the KLF family, and three C2H2 type zinc fingers are located at its C-terminus that bind to the promoters of target genes [13]. KLF7 could regulate the function of the nervous system and adipose tissue [14]. Knockdown the expression of KLF7 may cause damages to neuronal and cardiomyocytic differentiation of embryonic stem cells [15]. Besides, the abnormal expression of KLF7 may be also involved in regulation of blood disease, type 2 diabetes, obesity, etc [16–18]. Recently, tumor investigations have demonstrated that abnormal expression of KLF7 might be involved in carcinogenesis. For example, Ding et al. reported that the expression of KLF7 was up-regulated in OSCC tissues, moreover, its elevated expression showed positive association with the migration ability of OSCC cells. KLF7 might serve as a promoter in metastasis of OSCC [19]. However, to our knowledge the prognostic significance of KLF7 in OSCC remained unclear.

In the present study, we analyzed the relative expression level of KLF7 in OSCC carcinoma tissues, as well as its association with clinicopathological factors. In addition, a five-year follow up investigation was performed for the patients, and the clinical significance of KLF7 for prognosis prediction in OSCC patients was also investigated in the current study.

Patients and tissue samples

The study was approved by the Ethic Committee of Chinese PLA General Hospital. All patients provided written informed consents in advance.

In the present study, a total of 111 OSCC cases were recruited from Chinese PLA General Hospital. All patients were pathologically diagnosed with OSCC and did not receive any treatment prior. The tumor tissues and adjacent non-cancerous tissue specimens were collected from each patient, then the specimens were immediately frozen in liquid nitrogen and stored at -80 ℃ until use.

All the patients were enrolled in a five-year follow up investigations. The survival information during the follow-up was recorded for survival analysis. The patients whose death was not related to OSCC would be excluded from the study.

RNA extraction and quantitative real-time polymerase chain reaction (qRT-PCR)

Total RNA was extracted from OSCC tumor specimens and matched adjacent non-tumor tissues using TRIzol reagent (Invitrogen) according to the manufacturer’s procedure. The expression level of KLF7 was determined by qRT-PCR, and the reaction was performed with the SYBR® Green dye (TaKaRa, Dalian, China) on the 7500 Real-Time PCR systems (Applied Biosystems, Carlsbad, CA, USA). β-actin served as internal control. The primer sequences were as follows: KLF7 forward (F), 5’-ACTGCTTGCTGACAATCTCG-3’ and reverse (R), 5’-GGTCCCTCACACATCCTTCA-3’; β-actin F, 5’-TGACGTGGACATCCGCAAAG-3’ and R, 5’-CTGGAAGGTGGACAGCGAGG-3’. The fold-change for target genes normalized by internal control was determined by 2^−ΔΔCT method. Each sample was examined in triplicate.

Statistical analysis

Statistical analysis were performed using SPSS statistics 18.0 (SPSS, Chicago, IL, USA) and the graph was plotted using GraphPad Prism 5.0 (GraphPad Software Inc., USA). The expression value of KLF7 in tissue specimens were shown as mean ± standard deviation (SD), and its comparison between tumor and non-cancerous specimens were carried out using student’s t test. The relationship between KLF7 expression levels and clinicopathologic characteristics was estimated by chi-square test. Kaplan-Meier curve was applied to analyze the effects of KLF7 expression on overall survival of OSCC cases. The prognostic value of KLF7 in OSCC was evaluated using Cox regression model. The P values less than 0.05 were considered statistically significant.

The expression level of KLF7 in OSCC

A total of 111 OSCC cases including 53 females and 58 males were collected in our study. QRT-PCR were used to investigate the expression pattern of KLF7 in the OSCC tissues and adjacent non-tumor tissues. The results showed that the relative expression of KLF7 was significantly increased in OSCC tissues compared with adjacent non-tumor tissues (P < 0.001) (Fig. 1).

The relationships between KLF7 expression and clinicopathological features

To assess the correlation of KLF7 expression with clinicopathological parameters of patients, the patients were divided into high KLF7 expression group (n = 56) and low KLF7 expression group (n = 55) based on their mean expression value. The expression levels of KLF7 were not correlated with age and gender (all P > 0.05 for both) (Table 1). However, the patients with high expression of KLF7 were more likely to exhibit advanced TNM stage (P = 0.006), large tumor size (P = 0.010), smoking (P = 0.006) and drinking (P = 0.000) (Table 1).

Table 1

The correlation between *KLF7* expression and clinicopathological features of OSCC patients
Features	NO. of cases (n = 111)	KLF7 expression		P values
Features	NO. of cases (n = 111)	Low (n = 55)	High (n = 56)	P values
Age (years)				0.218
< 60	48	27	21
≥ 60	63	28	35
Gender				0.298
Female	53	29	24
Male	58	26	32
Smoking status				0.006
None-smoker	51	18	33
Smoker	60	37	23
Tumor size (cm)				0.010
< 5	52	19	33
≥ 5	59	36	23
Drinking status				0.000
None-drinker	58	18	40
Drinker	53	37	16
TNM stage				0.006
Ⅰ-Ⅱ	53	19	34
Ⅲ-Ⅳ	58	36	22

The prognostic value of KLF7 expression in OSCC

In order to investigate the prognostic value of KLF7 expression for OSCC, we assessed the association between KLF7 expression levels and patient survival using Kaplan-Meier analysis with log-rank test. Survival analysis indicated that OSCC patients with high KLF7 expression had worse overall survival than those with low KLF7 expression (log rank test, P = 0.018) (Fig. 2). Univariate analysis revealed that KLF7 expression (P = 0.024), TNM stage (P = 0.029), smoking status (P = 0.026) and drinking status (P = 0.026) were potential prognostic indicators for OSCC patient. As shown in Table 2, multivariate analysis confirmed KLF7 expression (P = 0.002 HR = 2.645 95%CI: 1.426–4.906) and smoking status (P = 0.002; HR = 2.626; 95%CI: 1.415–4.871) were independently correlated with prognosis of OSCC patients.

Table 2

The univariate and multivariate analyses for patients with OSCC
Factors	Univariate analysis		Multivariate analysis
Factors	HR(95% CI)	P values	HR(95% CI)	P values
KLF7 expression	1.989 (1.096–3.608)	0.024	2.645 (1.426–4.906)	0.002
Age (years)	1.555 (0.856–2.828)	0.147	-	-
Gender	1.278 (0.719–2.272)	0.404	-	-
Smoking status	2.065 (1.090–3.915)	0.026	-	-
Drinking status	1.970 (1.085–3.574)	0.026	2.626 (1.415–4.871)	0.002
Tumor size (cm)	1.033 (0.575–1.853)	0.914	-	-
TNM stage	2.040 (1.076–3.868)	0.029	-	-

Oral squamous cell carcinoma (OSCC) is an aggressive human malignancy worldwide. Despite advances in prevention and treatment, the five-year survival rate of OSCC patients remains low due to metastasis and local recurrence [8, 20]. Tumor progression and prognosis evaluations are a great challenge for OSCC patients in clinic, due to the lack of effective and reliable biomarkers. Growing evidences have demonstrated that genetic factors play a pivotal role in progression of OSCC. Therefore, to investigate the OSCC-related genes may explore novel and effective biomarkers for patients with OSCC. In the present study, we investigated the prognostic value of KLF7 in OSCC patients.

KLFs are a family of zinc-finger transcription factors, which are widely expressed in multiple human organs or tissues [21]. KLF family is involved in diverse biological processes, and their abnormal expression may lead to human diseases, like cancer [22]. In oral cancer, several members of the KLFs family had been proved to be implicated in the pathogenesis of the cancers. For examples, Uchida D et al. had demonstrated that knockdown the expression of KLF2 would achieve the anti-tumor effects in oral cancer cells [23]. KLF4 and KLF5 might regulate the dedifferentiation and differentiation of oral carcinoma cells, thus leading to oral cancer carcinogenesis [24–26]. KLF8 was up-regulated in oral cancer cells, and its down-regulation might suppress the proliferation and clone formation of the cells [27]. In addition, the cellular levels of KLF13 was significantly correlated with proliferation ability and therapy sensitivity of oral cancer, which might be a potential diagnostic biomarker and therapeutic target for oral cancer [28]. However, to our knowledge, the function of KLF7 as well as its clinical significance had been rarely reported in OSCC.

In the present study, we found that KLF7 expression levels were up-regulated in OSCC tissues compared with adjacent non-tumor tissues. Additionally, the expression of KLF7 was positively correlated with tumor size, TNM stage, smoking status and drinking status. This data indicated that KLF7 might be involved in the development of OSCC. High expression of KLF7 predicted malignant clinical characteristics for the patients with OSCC. The study scheduled by Ding et al. have demonstrated that over-expression of KLF7 via mediating the expression of snail enhanced the migratory potential of OSCC cells, and induced epithelial-mesenchymal transition (EMT) and lymph node metastasis [19]. However, the carcinogenic mechanisms of KLF7 in OSCC was not investigated in the current study. Further relevant researches were still needed to address the issues.

Given its functional roles in OSCC development, we investigated the clinical performance of KLF7 in prognosis evaluation in OSCC population. Kaplan-Meier survival analysis with log-rank test suggested that high-expression group had obviously shorter overall survival than the low-expression group. Multivariate analysis with a Cox proportional hazards model indicated that high KLF7 expression was independently linked to poor survival of patients with OSCC. KLF7 might serve as an independent prognostic factor for patients with OSCC. Although we confirmed the prognostic value of KLF7 in OSCC, there were several limitations in our study. First, the sample size was relatively small. Second, only one single population was enrolled in our researches. Due to the diverse genetic background, the expression profile of KLF7 in other races might be different. In addition, despite of the diverse biomarkers confirmed for OSCC, few of then were applied in clinic. Thus, subsequent investigations still required to analyze the clinical application of KLF7 for OSCC cases.

In conclusion, the expression of KLF7 is increased in OSCC, and shows positive association with aggressive clinical parameters of OSCC cases. KLF7 may be an independent biomarker for prognosis prediction in OSCC.

Krüppel-like factor 7 (KLF7)

oral squamous cell carcinoma(OSCC)

quantitative real-time polymerase chain reaction (qRT-PCR)

Krüppel-like factors (KLFs)

standard deviation (SD)

epithelial-mesenchymal transition (EMT)

Ethics approval and consent to participate

This study was supported by the Ethics Committee of Chinese PLA General Hospital and also has been carried out in accordance with the World Medical Association Declaration of Helsinki.

The subjects had been informed the objective. Certainly, written consents were signed by every subject in this study.

Consent for publication

We obtaining permission from participants to publish their data.

Availability of data and materialsAll data generated or analysed during this study are included in this published article.

Competing interestsThe authors declare that they have no competing interests.

Authors’ contributions L.W. design of the work; L.W. the acquisition, analysis, H.S. interpretation of data; H.S. the creation of new software used in the work; S.Y. have drafted the work or substantively revised it. All authors read and approved the final manuscript.

Acknowledgements Not applicable.

Fungding:

The 63rd batch of grants from China Post-Doctoral Science Fund (2018M633673).

The 11th batch of special grants from China Post-Doctoral Science Fund (2018T111137).

Krishna Rao SV, Mejia G, Roberts-Thomson K, Logan R: Epidemiology of oral cancer in Asia in the past decade--an update (2000-2012). Asian Pacific journal of cancer prevention : APJCP 2013, 14(10):5567-5577.
Chou YE, Hsieh MJ, Hsin CH, Chiang WL, Lai YC, Lee YH, Huang SC, Yang SF, Lin CW: CD44 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan. PloS one 2014, 9(4):e93692.
Chuang CY, Chen MK, Hsieh MJ, Yeh CM, Lin CW, Yang WE, Yang SF, Chou YE: High Level of Plasma EGFL6 Is Associated with Clinicopathological Characteristics in Patients with Oral Squamous Cell Carcinoma. International journal of medical sciences 2017, 14(5):419-424.
Malik UU, Zarina S, Pennington SR: Oral squamous cell carcinoma: Key clinical questions, biomarker discovery, and the role of proteomics. Archives of oral biology 2016, 63:53-65.
Winck FV, Prado Ribeiro AC, Ramos Domingues R, Ling LY, Riano-Pachon DM, Rivera C, Brandao TB, Gouvea AF, Santos-Silva AR, Coletta RD et al: Insights into immune responses in oral cancer through proteomic analysis of saliva and salivary extracellular vesicles. Scientific reports 2015, 5:16305.
van der Waal I: Are we able to reduce the mortality and morbidity of oral cancer; some considerations. Medicina oral, patologia oral y cirugia bucal 2013, 18(1):e33-37.
Fang J, Li X, Ma D, Liu X, Chen Y, Wang Y, Lui VWY, Xia J, Cheng B, Wang Z: Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma. BMC cancer 2017, 17(1):375.
Abdul-Aziz MA, Amin AK, El-Rouby DH, Shaker OG: Lymphangiogenesis in Oral Squamous Cell Carcinoma: Correlation with VEGF-C Expression and Lymph Node Metastasis. International journal of dentistry 2017, 2017:7285656.
Cortegoso AVB, Laureano NK, Silva ADD, Danilevicz CK, Magnusson AS, Visioli F, Rados PV: Cell proliferation markers at the invasive tumor front of oral squamous cell carcinoma: comparative analysis in relation to clinicopathological parameters of patients. Journal of applied oral science : revista FOB 2017, 25(3):318-323.
Bieker JJ: Kruppel-like factors: three fingers in many pies. The Journal of biological chemistry 2001, 276(37):34355-34358.
Zhang Z, Wang H, Sun Y, Li H, Wang N: Klf7 modulates the differentiation and proliferation of chicken preadipocyte. Acta biochimica et biophysica Sinica 2013, 45(4):280-288.
McConnell BB, Yang VW: Mammalian Kruppel-like factors in health and diseases. Physiological reviews 2010, 90(4):1337-1381.
Wang X, Shen QW, Wang J, Zhang Z, Feng F, Chen T, Zhang Y, Wei H, Li Z, Wang Y: KLF7 Regulates Satellite Cell Quiescence in Response to Extracellular Signaling. Stem Cells 2016, 34(5):1310-1320.
Chen YC, Wei H, Zhang ZW: [Research progress of Kruppel-like factor 7]. Sheng li xue bao : [Acta physiologica Sinica] 2016, 68(6):809-815.
Caiazzo M, Colucci-D'Amato L, Esposito MT, Parisi S, Stifani S, Ramirez F, di Porzio U: Transcription factor KLF7 regulates differentiation of neuroectodermal and mesodermal cell lineages. Experimental cell research 2010, 316(14):2365-2376.
Schuettpelz LG, Gopalan PK, Giuste FO, Romine MP, van Os R, Link DC: Kruppel-like factor 7 overexpression suppresses hematopoietic stem and progenitor cell function. Blood 2012, 120(15):2981-2989.
Kawamura Y, Tanaka Y, Kawamori R, Maeda S: Overexpression of Kruppel-like factor 7 regulates adipocytokine gene expressions in human adipocytes and inhibits glucose-induced insulin secretion in pancreatic beta-cell line. Mol Endocrinol 2006, 20(4):844-856.
Zobel DP, Andreasen CH, Burgdorf KS, Andersson EA, Sandbaek A, Lauritzen T, Borch-Johnsen K, Jorgensen T, Maeda S, Nakamura Y et al: Variation in the gene encoding Kruppel-like factor 7 influences body fat: studies of 14 818 Danes. European journal of endocrinology / European Federation of Endocrine Societies 2009, 160(4):603-609.
Ding X, Wang X, Gong Y, Ruan H, Sun Y, Yu Y: KLF7 overexpression in human oral squamous cell carcinoma promotes migration and epithelial-mesenchymal transition. Oncology letters 2017, 13(4):2281-2289.
Taghavi N, Yazdi I: Prognostic factors of survival rate in oral squamous cell carcinoma: clinical, histologic, genetic and molecular concepts. Archives of Iranian medicine 2015, 18(5):314-319.
Sun F, Hu K: Kruppel-Like Factor 4 Inhibits the Transforming Growth Factor-beta1-Promoted Epithelial-to-Mesenchymal Transition via Downregulating Plasminogen Activator Inhibitor-1 in Lung Epithelial Cells. Disease markers 2015, 2015:473742.
Wang X, Jiang Z, Zhang Y, Liu L, Fan Z: RNA sequencing analysis reveals protective role of kruppel-like factor 3 in colorectal cancer. Oncotarget 2017, 8(13):21984-21993.
Uchida D, Onoue T, Begum NM, Kuribayashi N, Tomizuka Y, Tamatani T, Nagai H, Miyamoto Y: Vesnarinone downregulates CXCR4 expression via upregulation of Kruppel-like factor 2 in oral cancer cells. Molecular cancer 2009, 8:62.
Li W, Liu M, Su Y, Zhou X, Liu Y, Zhang X: The Janus-faced roles of Kruppel-like factor 4 in oral squamous cell carcinoma cells. Oncotarget 2015, 6(42):44480-44494.
Shibata M, Chiba T, Matsuoka T, Mihara N, Kawashiri S, Imai K: Kruppel-like factors 4 and 5 expression and their involvement in differentiation of oral carcinomas. International journal of clinical and experimental pathology 2015, 8(4):3701-3709.
Kim CK, He P, Bialkowska AB, Yang VW: SP and KLF Transcription Factors in Digestive Physiology and Diseases. Gastroenterology 2017, 152(8):1845-1875.
Bin Z, Ke-Yi L, Wei-Feng Z, Li-Cheng J, Xian-Bin L, Chun-Peng X, Dao-Ying Y, Shu-Wei L: Downregulation of KLF8 expression by shRNA induces inhibition of cell proliferation in CAL27 human oral cancer cells. Medicina oral, patologia oral y cirugia bucal 2013, 18(4):e591-596.
Henson BJ, Gollin SM: Overexpression of KLF13 and FGFR3 in oral cancer cells. Cytogenetic and genome research 2010, 128(4):192-198.

Download PDF

Version 1

posted

You are reading this latest preprint version

Relationship of Common Variants in Krüppel-like Factor 7 Gene With Susceptibility and Prognosis of Oral Squamous Cell Carcinoma

Status:

Version 1

Abstract

Figures

Background

Materials And Methods

Patients and tissue samples

RNA extraction and quantitative real-time polymerase chain reaction (qRT-PCR)

Statistical analysis

Results

The expression level of KLF7 in OSCC

The relationships between KLF7 expression and clinicopathological features

The prognostic value of KLF7 expression in OSCC

Discussion

Conclusions

Abbreviations

Declarations

References

Status:

Version 1